
Bellevue Life Sciences Acquisition Corp. – NASDAQ:BLAC
Bellevue Life Sciences Acquisition Corp. stock price today
Bellevue Life Sciences Acquisition Corp. stock price monthly change
Bellevue Life Sciences Acquisition Corp. stock price quarterly change
Bellevue Life Sciences Acquisition Corp. stock price yearly change
Bellevue Life Sciences Acquisition Corp. key metrics
Market Cap | 45.54M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 0.01 |
Revenue | N/A |
EBITDA | -2.00M |
Income | 233.04K |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBellevue Life Sciences Acquisition Corp. stock price history
Bellevue Life Sciences Acquisition Corp. stock forecast
Bellevue Life Sciences Acquisition Corp. financial statements
Jun 2023 | 0 | 301.46K | |
---|---|---|---|
Sep 2023 | 0 | 78.18K | |
Dec 2023 | 0 | -86.17K | |
Mar 2024 | 0 | -60.43K |
Jun 2023 | 71494506 | 2.61M | 3.65% |
---|---|---|---|
Sep 2023 | 72136443 | 3.17M | 4.4% |
Dec 2023 | 36627733 | 4.10M | 11.22% |
Mar 2024 | 37274110 | 4.81M | 12.92% |
Jun 2023 | -347.62K | 0 | 0 |
---|---|---|---|
Sep 2023 | -143.22K | 0 | 200K |
Dec 2023 | -279.49K | 36.37M | -36.14M |
Mar 2024 | -41.78K | -120K | 150K |
Bellevue Life Sciences Acquisition Corp. other data
Period | Buy | Sel |
---|---|---|
Feb 2023 | 860000 | 0 |
-
What's the price of Bellevue Life Sciences Acquisition Corp. stock today?
One share of Bellevue Life Sciences Acquisition Corp. stock can currently be purchased for approximately $2.81.
-
When is Bellevue Life Sciences Acquisition Corp.'s next earnings date?
Unfortunately, Bellevue Life Sciences Acquisition Corp.'s (BLAC) next earnings date is currently unknown.
-
Does Bellevue Life Sciences Acquisition Corp. pay dividends?
No, Bellevue Life Sciences Acquisition Corp. does not pay dividends.
-
How much money does Bellevue Life Sciences Acquisition Corp. make?
Bellevue Life Sciences Acquisition Corp. has a market capitalization of 45.54M.
-
What is Bellevue Life Sciences Acquisition Corp.'s stock symbol?
Bellevue Life Sciences Acquisition Corp. is traded on the NASDAQ under the ticker symbol "BLAC".
-
What is Bellevue Life Sciences Acquisition Corp.'s primary industry?
Company operates in the Financial Services sector and Shell Companies industry.
-
How do i buy shares of Bellevue Life Sciences Acquisition Corp.?
Shares of Bellevue Life Sciences Acquisition Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Bellevue Life Sciences Acquisition Corp. went public?
Bellevue Life Sciences Acquisition Corp. is publicly traded company for more then 2 years since IPO on 21 Mar 2023.
-
Where are Bellevue Life Sciences Acquisition Corp.'s headquarters?
Bellevue Life Sciences Acquisition Corp. is headquartered at 10900 NE 4th Street, Bellevue, WA.
-
How can i contact Bellevue Life Sciences Acquisition Corp.?
Bellevue Life Sciences Acquisition Corp.'s mailing address is 10900 NE 4th Street, Bellevue, WA and company can be reached via phone at 425 635 7700.
Bellevue Life Sciences Acquisition Corp. company profile:
NASDAQ
0
Shell Companies
Financial Services
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Bellevue, WA 98004
CIK: 0001840425
ISIN: US0791741087
CUSIP: 079174108